Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

NCT00928252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Hormone Refractory Prostate Cancer

Interventions

DRUG: IV fluorine-18 labeled methylcholine before PET/CT

Sponsor

Queen's Medical Center

Collaborators

[object Object]
[object Object]